Pharmacodynamic Changes in Tumor and Immune Cells Drive Iberdomide’s Clinical Mechanisms of Activity in Relapsed and Refractory Multiple Myeloma
CELL REPORTS MEDICINE（2024）
关键词
iberdomide,cereblon,myeloma,IMiD refractory,CC-220,immune stimulatory
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要